How often should I retest my blood biomarkers?

How often you should retest blood biomarkers depends on which tests, your health status, whether you’re on treatment, and any recent changes (symptoms, new meds, lifestyle change). Below is a practical, clinician‑style summary you can use to plan testing plus recommended lab services.

General principles

• Normal + low risk: test less often (months–years).
• Abnormal, on treatment, or changing therapy: test more often (weeks–months) until stable.
• New symptoms, pregnancy, starting/stopping meds, or major lifestyle change → test sooner.
• Coordinate a testing schedule with your clinician so results are interpreted and acted on.

Typical frequency by biomarker (common tests)

• Lipid panel (total cholesterol, LDL, HDL, triglycerides)
  • Healthy, low risk: every 4–6 years (adult screening).
  • On statin or abnormal: 4–12 weeks after initiation or dose change, then every 3–12 months once stable.
• HbA1c (long‑term glucose control)
  • Diabetes with changes or not at goal: every 3 months.
  • Diabetes stable and at goal: every 6 months.
  • Prediabetes: every 6–12 months.
• Fasting glucose
  • As needed for screening or with symptoms; often done with HbA1c.
• Basic metabolic panel / CMP (electrolytes, kidney, liver tests)
  • Healthy: once yearly or with annual physical.
  • On meds affecting kidneys/liver or with abnormal results: more frequently (weeks–months).
• Liver enzymes (ALT/AST)
  • Baseline, then as clinically indicated; if abnormal or on hepatotoxic meds, repeat in weeks–months.
• Thyroid stimulating hormone (TSH)
  • Starting or changing levothyroxine/antithyroid drugs: check ~6 weeks after change.
  • Stable on therapy: every 6–12 months.
• Complete blood count (CBC)
  • Routine healthy adults: annually or as part of workup.
  • If anemia or cytopenia or on meds that affect blood counts: repeat as directed (weeks–months).
• Vitamin D (25‑OH D)
  • If deficient and repleting: recheck in 8–12 weeks after starting supplementation.
  • If adequate: every 6–12 months if risk factors.
• High‑sensitivity CRP / inflammatory markers
  • Use case‑specific (cardiac risk tracking or inflammatory disease). Frequency depends on reason — often every 3–12 months if monitoring disease activity.
• PSA (prostate-specific antigen)
  • Shared decision-making with clinician; if chosen, frequency often every 1–4 years depending on age and risk.
• Therapeutic drug monitoring / INR / specialty labs
  • Follow specific therapy protocols (e.g., INR testing frequently until stable with warfarin; then interval lengthens).

Example schedules

• Healthy adult, no chronic disease: baseline labs (CBC, CMP, lipid panel, fasting glucose or HbA1c, TSH, vitamin D) then mostly annual or every few years as above.
• Person with type 2 diabetes: HbA1c every 3 months until controlled, then every 6 months; CMP and lipids per clinician; more frequent if meds change.
• Starting statin: lipid check 4–12 weeks after start/change, then every 3–12 months.

Practical testing options (brands/services)

• Large clinical labs: Quest Diagnostics, LabCorp — broad test menu, widely accepted by clinicians and insurers.
• Direct‑to‑consumer/home kits: Everlywell, LetsGetChecked, HealthLabs, or myLAB Box — convenient for basic panels (cholesterol, HbA1c, hormones), but check accuracy and follow up with your clinician for abnormal results.
• Continuous glucose monitoring (if recommended for diabetes): Dexcom, Abbott FreeStyle Libre.
• Home INR monitoring for warfarin: CoaguChek.

Tips

• Ask whether fasting is required (many lipid panels can be nonfasting now). Morning draws are preferred for some hormones.
• Keep copies of past labs to track trends rather than single values.
• Always discuss abnormal results or changes with your clinician before changing medications.

If you tell me which specific biomarkers you’re tracking, whether you have any diagnoses or medications, and your age, I can give a more tailored retesting schedule.